Patients with epilepsy have a higher risk regarding low quality of life. Objective: to determine the impact of different clinical and demographic factor upon the quality of life. Material and methods: the study group was comprised by 113 patients diagnosed with epilepsy, evaluated between 01.03.2008 and 31.03.2010 in Neurology Clinic from Cluj-Napoca
Neuropathic pain (NeuP) is challenging to diagnose and manage, despite ongoing improved understanding of the underlying mechanisms. Many patients do not respond satisfactorily to existing treatments. There are no published guidelines for diagnosis or management of NeuP in South Africa.
Studies of pregabalin for the treatment of central neuropathic pain have been limited to double-blind trials of 4–17 weeks in duration. The purpose of this study was to assess the long-term safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. The efficacy of pregabalin was also assessed as a secondary measure.
Epilepsy is a group of neurological conditions in which there is a pathological and enduring predisposition to generate recurrentrnseizures. Evidence over the last few decades suggests that epilepsy may be associated with increased sleep-disordered breathing,rnwhich may contribute towards sleep fragmentation, daytime somnolence, reduced seizure control, and cardiovascular-relatedrnmorbidity and…
Chronic pain is complex physiologically and there are many influences on the pain experience. The approach to treatment therefore needs to be multimodal, often with a number of different interventions, both physical and psychological, delivered in parallel